Depakine Chrono

Depakine Chrono may be available in the countries listed below.

Ingredient matches for Depakine Chrono

Valproic Acid

Valproic Acid is reported as an ingredient of Depakine Chrono in the following countries:

• Poland

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Depakine Chrono in the following countries:

• Austria


• Czech Republic


• Hungary


• Lithuania


• Luxembourg


• Portugal


• Switzerland


• Taiwan

International Drug Name Search

Gliclazide Zydus

Gliclazide Zydus may be available in the countries listed below.

Ingredient matches for Gliclazide Zydus

Gliclazide

Gliclazide is reported as an ingredient of Gliclazide Zydus in the following countries:

• France

International Drug Name Search

Gynazole-1

Gynazole-1 is a brand name of butoconazole topical, approved by the FDA in the following formulation(s):

GYNAZOLE-1 (butoconazole nitrate - cream; vaginal)

• 
  Manufacturer: KV PHARM
  
  Approval date: February 7, 1997
  
  Strength(s): 2% ^[RLD]

Has a generic version of Gynazole-1 been approved?

No. There is currently no therapeutically equivalent version of Gynazole-1 available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Gynazole-1. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pharmaceutical preparations and methods for their administration
  Patent 5,993,856
  Issued: November 30, 1999
  Inventor(s): Ragavan; Vanaja V. & DiPiano; Gerrianne M.
  Assignee(s): FemmePharma
  Formulations which have been developed for topical or local delivery intrapelvically, intraperitoneally or directly on reproductive organs of interest administration to a region such as the female reproductive system, provide for increased comfort, increased bioavailability, rapid and relatively high blood levels in the regions to be treated in the substantial absence of systemic levels of drug which might cause side effects. These formulations consist of drug micro or nanoparticles, which may be formed of drug alone or in combination with an excipient or polymeric carrier. The excipient or polymer may be used to manipulate release rates and to increase adhesion to the affected region. The particulate formulation can be applied as a dried powder, a liquid suspension or dispersion, or as a topical ointment, creme, lotion, foam or suppository.
  
  Patent expiration dates:
  
  
  • November 17, 2017
    
    ✓ 
    Patent use: METHOD OF TREATING A VAGINAL FUNGAL INFECTION IN A FEMALE HUMAN
    ✓ 
    Drug product
  
  

See also...

• Gynazole-1 Cream Consumer Information (Wolters Kluwer)
• Gynazole 1 Consumer Information (Cerner Multum)
• Butoconazole Cream Consumer Information (Wolters Kluwer)
• Butoconazole vaginal Consumer Information (Cerner Multum)
• Butoconazole AHFS DI Monographs (ASHP)

Oramorph

UK matches:

• Oramorph Concentrated Oral Solution
• Oramorph Oral Solution

Ingredient matches for Oramorph

Morphine

Morphine sulphate pentahydrate (a derivative of Morphine) is reported as an ingredient of Oramorph in the following countries:

• Austria


• Belgium


• France


• Greece


• Ireland


• Italy


• Luxembourg


• Netherlands


• Spain


• Sweden


• United Kingdom


• United States

International Drug Name Search

Gasmilen

Gasmilen may be available in the countries listed below.

Ingredient matches for Gasmilen

Ganciclovir

Ganciclovir sodium salt (a derivative of Ganciclovir) is reported as an ingredient of Gasmilen in the following countries:

• Argentina

International Drug Name Search

Trovir

Trovir may be available in the countries listed below.

Ingredient matches for Trovir

Lamivudine

Lamivudine is reported as an ingredient of Trovir in the following countries:

• Myanmar

Nevirapine

Nevirapine is reported as an ingredient of Trovir in the following countries:

• Myanmar

Zidovudine

Zidovudine is reported as an ingredient of Trovir in the following countries:

• Myanmar

International Drug Name Search